Details

Autor(en) / Beteiligte

• Miyamoto, Tetsu
• Nishino, Tomoya
• Nakata, Takashi
• Sato, Yuji
• Komatsu, Hiroyuki
• Uramatsu, Tadashi
• Ishimatsu, Nana
• Ishida, Kaede
• Serino, Ryota
• Otsuji, Yutaka
• Miyazaki, Masanobu
• Tomo, Tadashi
• Tamura, Masahito
• Fujimoto, Shouichi

Titel

Impact of tonsillectomy combined with steroid pulse therapy on immunoglobulin A nephropathy depending on histological classification: a multicenter study

Ist Teil von

• Clinical and experimental nephrology, 2016-02, Vol.20 (1), p.50-57

Ort / Verlag

Tokyo: Springer Japan

Erscheinungsjahr

2016

Link zum Volltext

Quelle

SpringerLink (Online service)

Beschreibungen/Notizen

• Background In addition to corticosteroids and inhibition of the renin–angiotensin–aldosterone system, tonsillectomy with steroid pulse therapy (TSP) may have a beneficial impact on the clinical course of IgA nephropathy (IgAN). However, there is still much uncertainty regarding the indications for therapy, treatment protocol, and therapeutic options for IgAN. Methods In this multicenter retrospective cohort study, we enrolled 284 patients with biopsy-proven IgAN who received TSP or corticosteroid therapy or conservative therapy. The effects of TSP on clinical remission (CR) were evaluated after a median follow-up period of 4.1 years in relation to histological classifications. Results Among the 284 participants, 161 patients received TSP. During the observation time, 141 patients (49.6 %) achieved CR, with a median time to remission of 397 days. In multivariate Cox regression analyses, TSP had an impact on achieving CR in only the group with histological grade 3 defined as glomerulosclerosis, crescent formation or adhesion to Bowman’s capsule in 10–30 % of all biopsied glomeruli, or mild cellular infiltration in the interstitium (hazard ratio (HR) 4.29, 95 % confidence interval (95 %CI) 1.88–11.19, P  < 0.001). TSP independently contributed to a higher incidence of CR, particularly in the patient group showing evident mesangial hypercellularity (HR 2.54, 95 %CI 1.38–5.08, P  = 0.002). Conclusions TSP may have a beneficial effect on the clinical course in IgAN patients with mild to moderate glomerular and interstitial lesions, particularly with distinct mesangial cell proliferation.